surface-enhanced laser desorption/ionization-time of flight mass spectrometry

OTHER6 trials

Sponsors

National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Gynecologic Oncology Group, Charing Cross Hospital, SWOG Cancer Research Network

Conditions

Breast CancerCervical CancerFallopian Tube CancerLung CancerOvarian CancerPancreatic CancerPrimary Peritoneal Cavity Cancer

Phase 2

Gefitinib in Treating Patients With Cervical Cancer

CompletedNCT00049556

National Cancer Institute (NCI)Cervical Cancer, Fallopian Tube Cancer, Ovarian Cancer +1

Start: 2002-10-31End: 2006-08-31Updated: 2013-06-20

Phase 3

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Charing Cross HospitalBreast Cancer

Start: 2007-01-31Target: 1000Updated: 2013-08-07

Unknown Phase

Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions

CompletedNCT00077324

Alliance for Clinical Trials in OncologyLung Cancer

Start: 2004-02-29End: 2011-11-30Updated: 2016-07-06

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Gynecologic Oncology GroupFallopian Tube Cancer, Ovarian Cancer

Start: 2005-10-31Target: 2000Updated: 2010-02-09

Identification of Biomarkers for Early Detection of Pancreatic Cancer

CompletedNCT00897494

Barbara Ann Karmanos Cancer InstitutePancreatic Cancer

Start: 2005-02-28End: 2011-04-30Updated: 2016-03-09

SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897

CompletedNCT00896623

SWOG Cancer Research NetworkBreast Cancer

Start: 2006-12-31End: 2007-06-30Updated: 2017-02-17